2P-S3-2
PATHOGENESIS AND PREVENTION OF PERIVENTRICULAR LEUKOMALACIA AND
PONTOSUBICULAR NECROSIS
Takashima S
National Institute of Neuroscience, National Center of Neurology and
Psychiatry, Tokyo, Japan
Fetal and
neonatal hypoxic-ischemic encephalopathy is an important cause of cerebral
palsy and intellectual impairment. There are several types of perinatal brain
damage as to its localized distribution due to kinds of hypoxic-ischemic causes
and brain maturity. Their pathogenesis may be different in each type.
Periventricular leukomalacia (PVL) occurs in the deep white matter of preterm
infants, and ponto- subicular necrosis (PSN) in the pontine nuclei and
subiculum of preterm and term neonate brains.
In the pathogenesis on PVL, the development of cerebral vasculature and the
differentiation of glial cells in deep white matter is very important as
predisposing factors. As causal factors, the cerebral hypoperfusion in
perinatal period causes axonal damage, release glutamate, increase cytokine in
microglia and nerve growth factor in astrocyte, and finally induces plasticity
in neurons and oligodendrocytes. These cellar reactivation after PVL may be
important to determine effective time of treatment and rehabilitation.
In neuropathology of neonates, there is another important lesion, PSN, which is
characterized by neuronal karyorrhexis in the pontine nucleus and subiculum of
perinatal brains aged from 28 weeks of gestation to 2 months after birth. This
PSN has rather the characters of apoptosis such as karyorrhexis, cellular
atrophy and few glial reaction. The developmental discrepancy between neurons
exhibiting late maturation and vessels showing an early increase in the basis
pontis and subiculum may predispose fetuses and neonates to the production of
PSN. As causal factors, ischemia, hyperogygenemia and hypocarbia are reported.
Nestin, abundant in multipotential stem cells, is reactivated in sur- rounding
cells of the subacute and chronic lesions. Thus, local plasticity may be
activated both in necrotic and apoptotic cell death, and important for
treatment.